SKI Market

A+| A| A-|

Indian Indices

Sensex

76,551.40 287.07
( 0.38%)

Global Indices

Nasdaq

51,705.57 482.31
(0.94%)

Dow Jones

7,575.20 122.74
(1.65%)

Hang Seng

69,318.21 3,298.17
(5.00%)

Nikkei 225

10,435.69 -36.03
(-0.34%)

Forex

USD-INR

94.92 -0.57
(-0.60%)

EUR-INR

109.83 -0.42
(-0.38%)

GBP-INR

127.25 -0.49
(-0.38%)

JPY-INR

0.59 0.00
(-0.48%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Ajanta Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

532331

INE031B01049

338.0498657

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AJANTPHARM

40.36

38214.68

EPS(TTM)

Face Value()

Div & Yield %

75.78

0.92

Back

Cenlub Industries standalone net profit declines 44.85% in the December 2025 quarter

Feb 14,2026

Net profit of Cenlub Industries declined 44.85% to Rs 1.07 crore in the quarter ended December 2025 as against Rs 1.94 crore during the previous quarter ended December 2024. Sales declined 4.67% to Rs 15.93 crore in the quarter ended December 2025 as against Rs 16.71 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	15.93	16.71	-5
OPM %	7.66	13.76	-
PBDT	1.66	2.79	-41
PBT	1.43	2.59	-45
NP	1.07	1.94	-45

76,551.40 287.07 ( 0.38%)

51,705.57 482.31 (0.94%)

7,575.20 122.74 (1.65%)

69,318.21 3,298.17 (5.00%)

10,435.69 -36.03 (-0.34%)

94.92 -0.57 (-0.60%)

109.83 -0.42 (-0.38%)

127.25 -0.49 (-0.38%)

0.59 0.00 (-0.48%)